Incidence and prevalence of CIDP and the association of diabetes mellitus
Abstract
Background: The reported prevalence of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) varies greatly, from 1.9 to 7.7 per 100,000. CIDP is reported to occur more commonly in patients with diabetes mellitus (DM) but has not been rigorously tested.
Objectives: To determine the incidence (1982–2001) and prevalence (on January 1, 2000) of CIDP in Olmsted County, Minnesota, and whether DM is more frequent in CIDP.
Methods: CIDP was diagnosed by clinical criteria followed by review of electrophysiology. Cases were coded as definite, probable, or possible. DM was ascertained by clinical diagnosis or current American Diabetes Association glycemia criteria.
Results: One thousand five hundred eighty-one medical records were reviewed, and 23 patients (10 women and 13 men) were identified as having CIDP (19 definite and 4 probable). The median age was 58 years (range 4–83 years), with a median disease duration at diagnosis of 10 months (range 2–64 months). The incidence of CIDP was 1.6/100,000/year. The prevalence was 8.9/100,000 persons on January 1, 2000. Only 1 of the 23 CIDP patients (4%) also had DM, whereas 14 of 115 age- and sex-matched controls (12%) had DM.
Conclusions: 1) The incidence (1.6/100,000/year) and prevalence (8.9/100,000) of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are similar to or higher than previous estimates. 2) The incidence of CIDP is similar to that of acute inflammatory demyelinating polyradiculoneuropathy within the same population. 3) Diabetes mellitus (DM) is unlikely to be a major risk covariate for CIDP, but we cannot exclude a small effect. 4) The perceived association of DM with CIDP may be due to misclassification of other forms of diabetic neuropathies and excessive emphasis on electrophysiologic criteria.
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
File (laughlin.pdf)
- Download
- 544.98 KB
REFERENCES
1.
Hahn AF, Hartung H, Dyck PJ. Chronic inflammatory demyelinating polyradiculopathy. In: Dyck PJ, Thomas PK, eds. Peripheral Neuropathy,
2.
Adams RD, Asbury AK, Michelsen JJ. Multifocal pseudohypertrophic neuropathy. Trans Am Neurol Assoc 1965;90:30.
3.
Austin J. Recurrent polyneuropathies and their corticosteroid treatment: with five-year observations of a placebo-controlled case treated with corticotrophin cortisone and prednisone. Brain 1958;81:157.
4.
Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaaki H, Groover RV. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 1975;50:621–637.
5.
Cornblath DR, Asbury AK, Albers JW, Feasby TF, Hahn AF, Mcleod J. Report from an ad hoc subcommittee of the American Academy of Neurology AIDS Task Force: research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617–618.
6.
Lunn MP, Manji H, Choudhary PP, Hughes RA, Thomas PK. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 1999;66:677–680.
7.
McLeod JG, Pollard JD, Macaskill P, Mohamed A, Spring P, Khurana V. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol 1999;46:910–913.
8.
Mygland A, Monstad P. Chronic polyneuropathies in Vest-Agder, Norway. Eur J Neurol 2001;8:157–165.
9.
Iijima M, Koike H, Hattori N, et al. Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population. J Neurol Neurosurg Psychiatry 2008;79:1040–1043.
10.
Miyasaki H, Hasegawa O, Mori I, Matsumoto S, Arita T. Incidence of diabetic neuropathy which fulfills electrophysiologic criteria of CIDP [in Japanese]. No To Shinkei 1999;51:415–418.
11.
Chio A, Cocito D, Bottacchi E, et al. Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy. J Neurol Neurosurg Psychiatry 2007;78:1349–1353.
12.
Gorson KC, Ropper AH, Adelman LS, Weinberg DH. Influence of diabetes mellitus on chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2000;23:37–43.
13.
Haq RU, Pendlebury WW, Fries TJ, Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients. Muscle Nerve 2003;27:465–470.
14.
Krendel DA, Costigan DA, Hopkins LC. Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol 1995;52:1053–1061.
15.
Lozeron P, Nahum L, Lacroix C, Ropert A, Guglielmi JM, Said G. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients. J Neurol 2002;249:569–575.
16.
Sharma KR, Cross J, Farronay O, Ayyar DR, Shebert RT, Bradley WG. Demyelinating neuropathy in diabetes mellitus. Arch Neurol 2002;59:758–765.
17.
Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266–274.
18.
Daube JR, So ER. Application of clinical neurophysiology: assessing symptom complexes. In: Daube JR, ed. Clinical Neurophysiology,
19.
Panayiotopoulos CP, Chroni E. F-waves in clinical neurophysiology: a review, methodological issues and overall value in peripheral neuropathies. Electroencephalogr Clin Neurophysiol 1996;101:365–374.
20.
Bergstralh EJ, Offord KP, Chu CP, Beard CM, O'Fallon WM, Melton LJ. Calculating incidence, prevalence and mortality rates for Olmsted County, Minnesota: an update. Technical Report Series, No. 49. Rochester, MN: Section of Biostatistics, Mayo Clinic, April 1992.
21.
Nicolas G, Maisonobe T, Le Forestier N, Leger JM, Bouche P. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2002;25:26–30.
22.
Rotta FT, Sussman AT, Bradley WG, Ayyar DR, Sharma KR, Shebert RT. The spectrum of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 2000;173:129–139.
23.
Sander HW, Latov N. Research criteria for defining patients with CIDP. Neurology 2003;60:S8–S5.
24.
Van Den Bergh PYK, Pieret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelination polyradiculoneuropathy. Muscle Nerve 2004;29:565–574.
25.
Magda P, Latov N, Brannagan TH III, Weimer LH, Chin RL, Sander HW. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy. Arch Neurol 2003;60:1755–1759.
26.
Haq RU, Fries TJ, Pendlebury WW, et al. Chronic inflammatory demyelinating polyradiculopathy: a study of proposed electrodiagnostic and histologic criteria. Arch Neurol 2000;57:1745–1750.
27.
Bromberg MB. Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy. Muscle Nerve 1991;14:968–976.
28.
Lewis RA, Sumner AJ, Brown MJ, Asbury AK. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982;32:958–964.
29.
Katz JS, Saperstein DS, Gronseth G, Amato AA, Barohn RJ. Distal acquired demyelinating symmetric neuropathy. Neurology 2000;54:615–620.
30.
Kennedy RH, Danielson MA, Mulder DW, Kurland LT. Guillain-Barre syndrome: a 42-year epidemiologic and clinical study. Mayo Clin Proc 1978;53:93–99.
31.
Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain-Barre syndrome: incidence and mortality rates in US hospitals. Neurology 2008;70:1608–1613.
32.
Dyck PJB, Norell JE. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 1999;53:2113–2121.
33.
Dyck PJB, Windebank AJ. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve 2002;25:477–491.
34.
Garces-Sanches MDP, Engelstad J, Norell J, Dyck PJB. The pathological basis of painless diabetic lumbosacral radiculoplexus neuropathy. Neurology 2007;69: A70–A71.
Information & Authors
Information
Published In
Copyright
© 2009.
Publication History
Published online: June 29, 2009
Published in print: July 7, 2009
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Animal models of immune-mediated demyelinating polyneuropathies, Autoimmunity, 57, 1, (2024).https://doi.org/10.1080/08916934.2024.2361745
- Immune-Mediated Neuropathies: Top 10 Clinical Pearls, Seminars in Neurology, (2024).https://doi.org/10.1055/s-0044-1791579
- Prevalence and clinical implications of diabetes mellitus in autoimmune nodopathies: A systematic review, Journal of Diabetes and its Complications, 38, 12, (108883), (2024).https://doi.org/10.1016/j.jdiacomp.2024.108883
- Chronic Inflammatory Demyelinating Polyneuropathy, Neuroimmune Diseases, (1025-1052), (2024).https://doi.org/10.1007/978-3-031-60006-7_25
- Chronic Inflammatory Demyelinating Polyneuropathy, Neuroimmune Diseases, (1-28), (2024).https://doi.org/10.1007/978-3-031-24297-7_25-1
- Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy, Cochrane Database of Systematic Reviews, 2024, 5, (2024).https://doi.org/10.1002/14651858.CD001797.pub4
- Idiopathic Intracranial Hypertension Secondary to Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Cureus, (2023).https://doi.org/10.7759/cureus.43648
- Chronic Inflammatory Demyelinating Polyneuropathy and Evaluation of the Visual Evoked Potentials: A Review of the Literature, Medicina, 59, 12, (2160), (2023).https://doi.org/10.3390/medicina59122160
- Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: A Historical Perspective, Journal of Clinical Medicine, 12, 22, (6961), (2023).https://doi.org/10.3390/jcm12226961
- Chronic Immune-Mediated Demyelinating Neuropathies, CONTINUUM: Lifelong Learning in Neurology, 29, 5, (1357-1377), (2023).https://doi.org/10.1212/CON.0000000000001290
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.